Lingua: Inglese
Editore: VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2008
ISBN 10: 3639111672 ISBN 13: 9783639111675
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 80.
Da: preigu, Osnabrück, Germania
EUR 43,30
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Effects of Src-inhibitors on osteoclasts in vitro | Concerning inhibitory activity on osteoclastic bone resorption, viability of osteoclasts, and their differentiation from precursors | Stefanie Stummer | Taschenbuch | Englisch | VDM Verlag Dr. Müller | EAN 9783639111675 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 155,73
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Editore: Pfarre Niederhollabrunn, 2012
Da: Antiquariat Kastanienhof, Pirna, Germania
EUR 11,00
Quantità: 1 disponibili
Aggiungi al carrelloSoftcover. Condizione: Sehr gut. 21 x 17 cm Broschur, private Spiralbindung, Manuskriptdruck, SEHR GUTES EXEMPLAR--- Für Ihre Zufriedenheit versenden wir mit DHL und ausschließlich mit Trackingcode für eine sichere Sendungsverfolgung! Weitere Angebote unter antiquariat-kastanienhof , 84 Seiten. nein.
Lingua: Inglese
Editore: VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2008
ISBN 10: 3639111672 ISBN 13: 9783639111675
Da: Majestic Books, Hounslow, Regno Unito
EUR 76,51
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 80 23:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on White w/Gloss Lam.
Lingua: Inglese
Editore: VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2008
ISBN 10: 3639111672 ISBN 13: 9783639111675
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 77,91
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 80.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 49,59
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The human skeleton is continuously regenerated in order to repair damages of the bone and to maintain homeostasis. Disturbances in the process of remodelling can give rise to common bone disorders such as osteoporosis. In Osteoporosis the resorption of bone exceeds the formation of new bone resulting in loss of bone mass and fractures. Many people suffer from osteoporosis and other bone diseases and therefore it is important to search for effective pharmaceutical compounds. The Src inhibitor substances SI35, SI34, SI83, SI24, and S2 were studied for their effects on osteoclasts and bone remodelling in vitro. The aim was to investigate their functions on osteoclastic bone resorption activity and osteoclast differentiation from precursors. Also the effects on viability and the number of osteoclasts were examined. Src inhibitor substance SI83 had the strongest inhibitory activity in the resorption assays with coculture-derived osteoclasts as well as in the resorption assays with rabbit osteoclasts. All of the tested substances had an effect on the differentiation of osteoclasts derived from mouse coculture.